Zydus Cadila, part of Cadila Healthcare group, on Tuesday said it has received final approval from the US health regulator to market its generic version of Deferasirox tablets used in treatment of chronic iron overload due to blood transfusions.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2B724CB
via IFTTT
0 comments:
Post a Comment